These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Procedures and methods of benefit assessments for medicines in Germany. Bekkering GE; Kleijnen J Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905 [TBL] [Abstract][Full Text] [Related]
23. Dementia--quality health care and cost effectiveness of evaluation. Aita JF Nebr Med J; 1990 Apr; 75(4):64-5; discussion 65-6. PubMed ID: 2110631 [No Abstract] [Full Text] [Related]
24. [Integrated health care: do integrated health care contracts deliver what they promise?]. Grüner S; Haas H Z Orthop Unfall; 2007; 145(5):546-9. PubMed ID: 17955420 [No Abstract] [Full Text] [Related]
25. [Cooperating with nursing care]. Schumacher R Langenbecks Arch Chir Suppl Kongressbd; 1997; 114():746-51. PubMed ID: 9574258 [TBL] [Abstract][Full Text] [Related]
26. [Possibilities and limits of evaluation research: development of evaluation methods with an example]. Niechzial M; Nagel E; Pichlmayr R Langenbecks Arch Chir Suppl Kongressbd; 1997; 114():617-24. PubMed ID: 9574223 [TBL] [Abstract][Full Text] [Related]
27. [Networking nursing in the national and international context: requirements under economic factors]. Conrad J Pflege Z; 2010 Sep; 63(9):544-7. PubMed ID: 20922980 [No Abstract] [Full Text] [Related]
28. [Clinical treatment pathways: successful due to standardization. Better cooperation, clear responsibilities, cost overview and better quality]. Roeder N Chirurg; 2003 Jan; 74(1):M10-1. PubMed ID: 12643244 [No Abstract] [Full Text] [Related]
29. [Clinical treatment pathways--1: High quality at low cost--an incompatible goal conflict?]. Küttner T; Wiese M; Roeder N Pflege Z; 2005 Mar; 58(3):176-9. PubMed ID: 15801701 [No Abstract] [Full Text] [Related]
30. [Possibilities and limits of guidelines in medicine]. Lauterbach KW Z Arztl Fortbild Qualitatssich; 1998 Mar; 92(2):99-105. PubMed ID: 9577897 [TBL] [Abstract][Full Text] [Related]
32. [Cost reductions and their effects on drug research]. Götte D Med Klin (Munich); 2005 Jun; 100(6):309-13. PubMed ID: 15968482 [TBL] [Abstract][Full Text] [Related]
34. [Diabetes disease management program. What is its purpose?]. Stoschek J MMW Fortschr Med; 2006 May; 148(19):49, 51. PubMed ID: 16736710 [No Abstract] [Full Text] [Related]
35. [Surgical quality assurance in the largest federal district of Austria--introduction of a project]. Malekpour G; Bauer R; Griessner R; Salem G Z Arztl Fortbild Qualitatssich; 2000 Mar; 94(2):161-4. PubMed ID: 10782514 [TBL] [Abstract][Full Text] [Related]
36. [Structural and procedural quality of different orthopaedic rehabilitation settings: A comparison]. Dietsche S; Bürger W; Morfeld M; Koch U Rehabilitation (Stuttg); 2002; 41(2-3):103-11. PubMed ID: 12007034 [TBL] [Abstract][Full Text] [Related]
37. [USA health insurance system: illness is expensive]. Pieper M Pflege Z; 2001 Sep; 54(9):663-7. PubMed ID: 12150115 [No Abstract] [Full Text] [Related]
39. [Priorities in health care: what can we learn from the "Oregon Health Plan"?]. Marckmann G; Siebert U Dtsch Med Wochenschr; 2002 Jul; 127(30):1601-4. PubMed ID: 12143017 [No Abstract] [Full Text] [Related]
40. [Impact of the DRG system for subacute and rehabilitative treatment in Sydney, New South Wales, Australia]. Köhler F Rehabilitation (Stuttg); 2002 Feb; 41(1):10-3. PubMed ID: 11830788 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]